The growing prevalence of cardiovascular and thrombotic disorders is driving strong demand for D-dimer testing. As blood clot-related risk factors continue to increase, the need for precise diagnostic ...
The Global D-Dimer Testing Market is valued at approximately USD 1.37 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.1% over the forecast period 2024-2032. The ...
Venous thromboembolism (VTE) is a common disease that affects as many as 900,000 Americans yearly with an estimated 60,000 - 100,000 Americans dying each year as a result of VTE. D-Dimer levels ...
大阪大学発スタートアップの株式会社イムノセンス（本社：大阪府吹田市、代表取締役：杉原 宏和）は、超小型免疫測定プラットフォームGLEIAを応用した高濃度域用の心不全マーカー検査キット「GLEIAチェック NT‑proBNP(H)」についてクラスⅡ 体外診断用医薬 ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する